IE
AARD

Israel Englander’s Aardvark Therapeutics AARD Stock Holding History

Israel Englander’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Sell
69,948
-28,386
-29% -$133K ﹤0.01% 4932
2026
Q1 		$371K Sell
98,334
-385,006
-80% -$3.99M ﹤0.01% 4917
2025
Q4 		$6.34M Buy
483,340
+163,717
+51% +$2.04M ﹤0.01% 2750
2025
Q3 		$4.25M Buy
+319,623
New +$3.6M ﹤0.01% 3307
2025
Q2 		– Sell
-65,640
Closed -$493K – 6460
2025
Q1 		$493K Buy
+65,640
New +$737K ﹤0.01% 4820

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Israel Englander's AARD Position: Q2 2026 in Review

Israel Englander reduced its Aardvark Therapeutics (AARD) stake by 29% in Q2 2026, selling an estimated $133K and leaving 69,948 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #4932.

Israel Englander first reported a position in AARD in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.34M in Q4 2025. 72 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • Israel Englander held 69,948 shares of Aardvark Therapeutics worth $403K as of Q2 2026.
  • Israel Englander sold 28,386 Aardvark Therapeutics shares in Q2 2026, an estimated $133K.
  • Aardvark Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4932 holding.
  • Israel Englander first reported a position in Aardvark Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Israel Englander's Aardvark Therapeutics position peaked at $6.34M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.